the only announcements in the meantime will relate to ACV1 for neuropathic pain - i suspect these will be positive
in some respects i think MBP should consider a name change to reflect their wider drug portfolio
the only announcements in the meantime will relate to ACV1 for...
Add to My Watchlist
What is My Watchlist?